GP Investments Discloses 16.1% Zevia Stake After $20M Preferred Deal
ZVIA is trading near its 52-week low of $1.11 (11% above the low).
Summary
GP Investments reported a 16.1% as-converted stake in Zevia after buying $15 million of Series A preferred stock, with $5 million more contingent on 2026 sales of at least $172.5 million and Adjusted EBITDA of at least negative $3 million.
Key Events · Ownership and Investor Activity · ZVIA
-
GP Investments Reports 16.1% Stake
Bubble Holdings, GP Cash Management and GP Investments jointly report beneficial ownership of 13,812,154 Class A shares on an as-converted basis, approximately 16.1% of the class.
-
$20M Preferred Deal, $15M Funded
15,000 Series A preferred shares were issued at the October 22 initial closing for $15.0 million; a further 5,000 shares for $5.0 million are subject to a deferred closing.
-
Deferred $5M Has Operating Hurdles
The second tranche is conditioned on 2026 net sales of at least $172.5 million and Adjusted EBITDA of at least negative $3 million, unless Bubble waives the conditions or closes early.
-
Conversion at $1.448 With 14.4M Cap
Preferred converts at an initial $1.448 per share, above today's $1.23, with anti-dilution adjustments and an aggregate 14,428,844-share conversion cap.
Analysis · ZVIA · Manufacturing
GP Investments' fund now reports beneficial ownership of 13,812,154 Class A shares on an as-converted basis, about 16.1% of Zevia, following the October 22 purchase of 15,000 Series A preferred shares for $15 million, with another $5 million committed at a deferred closing. The conversion price of $1.448 sits above today's $1.23, so the stake is worth roughly $17.0 million at current prices (13,812,154 x $1.23) — a paper mark below the $20 million committed. The terms matter more than the headline: a board seat, standstill and 12-month transfer restrictions, a 20% proportional voting cap, 6% PIK-able dividends, and a redemption right at 1.5x issuance price after year four. That is a structured, protective position rather than an activist campaign, and the deferred $5 million hinges on 2026 net sales of at least $172.5 million and Adjusted EBITDA of at least negative $3 million — a hard operating bar the company must clear to get the full amount.
How filings like this one have moved
In the 30 days to Nov 12, 2026, 37% of the 3595 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ZVIA was trading at $1.23 on NYSE in the Manufacturing sector, with a market capitalization of approximately $95.1M. The 52-week trading range was $1.11 to $2.78. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.